Could the United States Benefit from a Lockdown? A Cost-Benefit Analysis

31 Pages Posted: 13 Jan 2021

Date Written: January 12, 2021

Abstract

Though COVID vaccines are finally available, the rate at which they are administered is slow, and in the meantime the pandemic continues to claim about as many lives every day as the 9/11 tragedy. I estimate that with the promised rate of vaccinations, if no additional non-pharmaceutical interventions are implemented, 406 thousand additional lives will be lost and the future cost of the pandemic will reach $2.4 trillion, or 11% of GDP. Using a cost-benefit analysis, I assess whether it is optimal for the United States to follow the lead of many European countries and introduce a nation-wide lockdown. I find that a lockdown would be indeed optimal and, depending on the assumptions, it should last between two and four weeks and will generate a net benefit of up to $1.2 trillion.

Keywords: COVID-19, Pandemic Curve, Cost-Benefit Analysis, Non-Pharmaceutical Interventions, Public Health Policy, Lockdown

JEL Classification: I10, I18

Suggested Citation

Scherbina, Anna D., Could the United States Benefit from a Lockdown? A Cost-Benefit Analysis (January 12, 2021). Available at SSRN: https://ssrn.com/abstract=3764250 or http://dx.doi.org/10.2139/ssrn.3764250

Anna D. Scherbina (Contact Author)

Brandeis University ( email )

415 South Street
Waltham, MA 02453
United States

HOME PAGE: http://sites.google.com/a/brandeis.edu/anna-scherbina/

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
157
Abstract Views
372
rank
227,542
PlumX Metrics